Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.
OBJECTIVE
To assess the efficacy of cisapride in reducing ileus persisting to the tenth postoperative day after neonatal abdominal surgery.


METHODS
A prospective, randomised, double blind trial comparing rectal cisapride (1.4-2.3 mg/kg/day) with placebo over seven days was undertaken in 33 neonates.


RESULTS
Seven of 12 (58%) patients receiving placebo and eight of 11 (73%) receiving cisapride achieved a first sustained feed during treatment. Of those receiving cisapride, the first sustained feed occurred at 2.3 days (SEM 0.6) compared with 4.7 days (SEM 0.8) with placebo. By the seventh day the mean daily net enteral balance was 69 (SEM 18) ml/kg in the cisapride subgroup and 17 (SEM 8) ml/kg for those receiving placebo. Stool was passed on 6.3 (SEM 0.4) treatment days in the cisapride subgroup compared with 4.1 (SEM 1.0) treatment days in the placebo subgroup.


CONCLUSIONS
Cisapride is effective in neonates with a prolonged ileus after abdominal surgery.
Lander
A
A
Department of Paediatric Surgery, Children's Hospital, Birmingham. 101366.153@compuserve.com
Redkar
R
R
Nicholls
G
G
Lawson
A
A
Choudhury
S R
SR
Corkery
J J
JJ
Gornall
P
P
Buick
R G
RG
Booth
I W
IW
D000285:Administration, Rectal; D020117:Cisapride; D004311:Double-Blind Method; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*; D011446:Prospective Studies
D005765:Gastrointestinal Agents; D010880:Piperidines; D020117:Cisapride